TipRanks
Go Ultimate55% OFF

Canopus Biopharma (CBIA) Financial Statements

Canopus Biopharma Financial Overview

Canopus Biopharma's market cap is currently $4.55K. The company's EPS TTM is $-0.01; its P/E ratio is -0.01; Canopus Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Aug 22Aug 21
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -764.56K$ -1.76K
EBITDA$ -764.56K$ -1.76K
Net Income$ -764.71K$ -1.75K
Balance Sheet
Cash & Short-Term Investments$ 4.21K$ 1.13K
Total Assets$ 4.21K$ 900.00
Total Debt$ 10.27K$ 0.00
Net Debt$ 6.06K$ -1.13K
Total Liabilities$ 17.50K$ 0.00
Stockholders' Equity$ -13.28K$ 900.00
Cash Flow
Free Cash Flow$ -6.18K$ -1.75K
Operating Cash Flow$ -6.18K$ -1.75K
Investing Cash Flow$ 0.00$ 0.00
Financing Cash Flow$ 10.40K$ 0.00

Currency in USD

Canopus Biopharma Earnings and Revenue History

-900K-600K-300K00 %0.4 %0.8 %1.2 %EarningsProfit Margin20212022RevenueEarningsProfit Margin

Canopus Biopharma Debt to Assets

08K16K24K0 %150 %300 %450 %LiabilitiesDebt to Assets20212022AssetsLiabilitiesDebt to Assets

Canopus Biopharma Cash Flow

-10K-5K05K10K15K20212022OperatingInvestingFinancing

Canopus Biopharma Forecast EPS vs Actual EPS